Abstract
The human hair cycle has four recognised phases; anagen, catagen, telogen, and exogen, with the duration of each phase being site specific. In scalp hair, telogen lasts for around 12 weeks, following which the telogen hair is shed, a process instigated by unknown factors in the exogen phase. Any disturbance to the hair cycle will induce a relative change in the equilibrium between growth and rest, initiating an acute telogen effluvium. It is essential therefore to identify the inducing factor so as to consider if any intervention is required; reassurance is frequently all that is needed. However, if the increase in hair shedding persists for 6 months or more (chronic telogen effluvium), then biochemical investigations are required. Frequently hair loss induces changes in the patient’s haircare and grooming routines resulting in an artificial increase in the observed lost hair, and understanding this potential confounding factor is essential. While not specifically part of this chapter, increased hair shedding occurs in patients in whom the hair density (hair per cm2) is also reduced.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Cash TF. The psychological effects of androgenetic alopecia in men. J Am Acad Dermatol. 1992;26(6):926–31.
Dawber RPR, Van Neste D. Hair and scalp disorders, common presenting signs differential diagnosis and treatment. London: Martin Dunitz; 1995. p. 262.
Du X, She E, Gelbart T, Truksa J, Lee P, Xia Y, et al. The serine protease TMPRSS6 is required to sense iron deficiency. Science. 2008;320(5879):1088–92.
Hård S. Non-anemic iron deficiency as an etiological factor in diffuse loss of hair of the scalp in women. Acta Derm Venereol. 1963;43:562–9.
Kantor J, Kessler LJ, Brooks DG, Cotsarelis G. Decreased serum ferritin is associated with alopecia in women. J Invest Dermatol. 2003;121(5):985–8.
Kingsley DH. The development and validation of a quality of life measure for the impact of androgen-dependent alopecia [Ph D]. Portsmouth: University of Portsmouth, School of Pharmacy & Biomedical Sciences; 1999.
Messenger AG, Rundegren J. Minoxidil: mechanisms of action on hair growth. Br J Dermatol. 2004;150(2):186–94.
Olsen EA, Reed KB, Cacchio PB, Caudill L. Iron deficiency in female pattern hair loss, chronic telogen effluvium, and control groups. J Am Acad Dermatol. 2010;63(6):991–9.
Park SY, Na SY, Kim JH, Cho S, Lee JH. Iron plays a certain role in patterned hair loss. J Korean Med Sci. 2013;28(6):934–8.
Pinkus H. Differential patterns of elastic fibers in scarring and non-scarring alopecias. J Cutan Pathol. 1978;5(3):93–104.
Prevezas C, Matard B, Pinquier L, Reygagne P. Irreversible and severe alopecia following docetaxel or paclitaxel therapy for breast cancer. Br J Dermatol. 2009;160:881–98.
Puolakka J. Serum ferritin in the evaluation of iron status in young healthy women. Acta Obstet Gynecol Scand. 1980;95(suppl):35–41.
Rasheed H, Mahgoub D, Hegazy R, El-Komy M, Abdel Hay R, Hamid MA, et al. Serum ferritin and vitamin d in female hair loss: do they play a role? Skin Pharmacol Physiol. 2013;26(2):101–7.
Rook A, Dawber RPR. In diseases of the hair and scalp. Oxford: Blackwell Scientific Press; 1982.
Rushton DH. Chemical and morphological properties of scalp hair in normal and abnormal states [PhD]. Cardiff: University of Wales; 1988.
Rushton DH. Management of hair loss in women. Dermatolog Clin. 1993a;11:47–53.
Rushton DH. Investigating and managing hair loss in apparently healthy women. Can J Dermatol. 1993b;5:455–61.
Rushton DH. Management of hair loss in women. Dermatol Clin. 1993c;11:47–53.
Rushton DH. Nutritional factors and hair loss. Clin Exp Dermatol. 2002;27(5):396–404.
Rushton DH, editor. Hepcidin, the iron-regulating peptide - what you need to know about its role in hair loss and, in particular, chronic telogen effluvium (CTE). Proceedings of the 7th World Congress for Hair Research. Edinburgh: J Investigative Dermatol; 2013.
Rushton DH, Barth JH. What is the evidence for gender differences in ferritin and haemoglobin? Crit Rev Oncol Hematol. 2010;73(1):1–9.
Rushton H, James KC, Mortimer CH. The unit area trichogram in the assessment of androgen-dependent alopecia. Br J Dermatol. 1983;109(4):429–37.
Rushton DH, Ramsay ID, James KC, Norris MJ, Gilkes JJ. Biochemical and trichological characterization of diffuse alopecia in women. Br J Dermatol. 1990;123(2):187–97.
Rushton DH, Ramsay ID, Gilkes JJ, Norris MJ. Ferritin and fertility. Lancet. 1991;337(8756):1554.
Rushton DH, Dover R, Sainsbury AW, Norris MJ, Gilkes JJ, Ramsay ID. Reference limits for haemoglobin and ferritin. BMJ. 2001;323:806–7.
Rushton DH, Dover R, Sainsbury AW, Norris MJ, Gilkes JJ, Ramsay ID. Iron deficiency is neglected in women’s health. BMJ. 2002a;325:1176–7.
Rushton DH, Norris MJ, Dover R, Busuttil N. Causes of hair loss and the developments in hair rejuvenation. Int J Cos Sci. 2002b;24:17–23.
Rushton DH, Dover R, Norris MJ. Is there really no clear association between low serum ferritin and chronic diffuse telogen hair loss? Br J Dermatol. 2003;148(6):1282–4.
Rushton DH, Ramsay ID, Gilkes JJH, editors. The use of placebo or untreated controls in male pattern hair loss leads to a significant and permanent loss of hair. London: Dermatology; 2006.
Rushton DH, Bergfeld WF, Gilkes JJ, Van Neste D. Iron deficiency and hair loss-nothing new? J Am Acad Dermatol. 2011;65(1):203–4; author reply 4–6.
Rushton DH, Norris MJ, Van Neste D. Hair regrowth in male and female pattern hair loss does not involve the conversion of vellus hair to terminal hair. Exp Dermatol. 2016;25:475–94.
Sinclair R. There is no clear association between low serum ferritin and chronic diffuse telogen hair loss. Br J Dermatol. 2002;147(5):982–4.
St. Pierre SA, Vercellotti GM, Donovan JC, Hordinsky M. Iron deficiency and diffuse nonscarring scalp alopecia in women: more pieces to the puzzle. J Am Acad Dermatol. 2010;63(6):1070–6.
Tallon B, Goldberg E, Goldberg LJ. Permanent chemotherapy-induced alopecia: case report and review of the literature. J Am Acad Dermatol. 2010;63(2):333–6.
Trost LB, Bergfeld WF, Calogeras E. The diagnosis and treatment of iron deficiency and its potential relationship to hair loss. J Am Acad Dermatol. 2006;54(5):824–44.
Van Neste DJ, Rushton DH. Hair problems in women. Clin Dermatol. 1997;15(1):113–25.
Van Neste D, Fuh V, Sanchez-Pedreno P, Lopez-Bran E, Wolff H, Whiting D, et al. Finasteride increases anagen hair in men with androgenetic alopecia. Br J Dermatol. 2000;143(4):804–10.
Van Neste D, Leroy T, Conil S. Exogen hair characterization in human scalp. Skin Res Technol. 2007;13(4):436–43.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Rushton, H.D. (2023). Acute and Chronic Telogen Effluvium. In: Katsambas, A.D., Lotti, T.M., Dessinioti, C., D'Erme, A.M. (eds) European Handbook of Dermatological Treatments. Springer, Cham. https://doi.org/10.1007/978-3-031-15130-9_95
Download citation
DOI: https://doi.org/10.1007/978-3-031-15130-9_95
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-15129-3
Online ISBN: 978-3-031-15130-9
eBook Packages: MedicineMedicine (R0)